Profund Advisors LLC Clovis Oncology, Inc. Transaction History

Profund Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $54,792 - $214,009	-13,942 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $21,008 - $42,098	-1,640 Reduced 10.52%	13,942 $207,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $1,059 - $1,816	60 Added 0.39%	15,582 $387,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $46,217 - $129,830	-3,974 Reduced 20.38%	15,522 $279,000
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $49,694 - $83,720	1,692 Added 9.5%	19,496 $573,000
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $9,547 - $14,164	227 Added 1.29%	17,804 $810,000
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $84,502 - $114,175	-1,686 Reduced 8.75%	17,577 $928,000
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $116,245 - $170,428	-2,015 Reduced 9.47%	19,263 $1.31 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $1.43 Million - $1.8 Million	21,278	21,278 $1.75 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.